AYTU:NASDAQ, Aytu BioPharma, Inc.

Why AYTU stock rose on November 17

Aytu BioPharma, Inc. rose 47.0% on Tuesday, November 17, 2026, on 4,429,694 shares, 78 times its average daily volume. Headlines around the move:

AYTU stock overview

Aytu BioPharma, Inc. (AYTU:NASDAQ) closed at $2.66 on November 17, 2026, up 46.96% on the day. The stock trades 13.4% below its 52-week high of $3.07 and 52.0% above its 52-week low of $1.75. Over the past year, it gained 31.7%. Aytu BioPharma, Inc. is part of the Health Care sector.

Key figures

Price
$2.66
Day change
+46.96%
Volume
4,429,694
Average volume
56,584
Market cap
28M+
52-week range
$1.75 – $3.07
50-day average
$2.01
200-day average
$2.27

Price action over the past year

In 252 trading sessions since November 17, 2025, AYTU closed higher on 121 days (48%). Its best day was November 17, 2026 (+46.15%) and its worst was February 4, 2026 (-10.31%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

AYTU news

About Aytu BioPharma, Inc.

Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, Cefaclor, Karbinal ER, and Poly-Vi-Flor and Tri-Vi-Flor.

Similar stocks

Find more stocks like AYTU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.